Woodward JM, Priest AN, Hollingsworth KG, Lomas DJ. Clinical
application of magnetic resonance spectroscopy of the liver in patients
receiving long term parenteral nutrition. JPEN J Parenter Enteral
Nutr. 2009;33:669
-676.
2.
Taylor-Robinson SD. Application of magnetic resonance spectroscopy
to chronic liver disease. Clin Med.2001
;1:54
-60.
3.
Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer-Smith J.
Examination of a case of suspected McArdle's disease by 31P nuclear magnetic
resonance. N Engl J Med.1981
;304:1338
-1342.
4.
Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance
spectroscopy in the liver: a review. Liver Int.2008
;28:297
-307.
5.
Solga SF, Horska A, Clark JM, Diehl AM. Hepatic 31P magnetic
resonance spectroscopy: a hepatologist's user guide. Liver Int.2005
;25:490
-500.
6.
Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance
spectroscopy to measure hepatic triglyceride content: prevalence of hepatic
steatosis in the general population. Am J Physiol Endocrinol
Metab. 2005;288:E462
-E468.
7.
Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content
and its relation to body adiposy: a magnetic resonance imaging and proton
magnetic resonance spectroscopy study. Gut.2005
;54:122
-127.
8.
Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment
of hepatic lipid composition: advancing understanding and management of fatty
liver disorders. Hepatology.2008
;47:1513
-1523.
9.
Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR
spectroscopic evaluation of the liver and correlation with histopathologic
findings. Radiology.2001
;221:740
-746.
10.
Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson
SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic
hepatitis C. Hepatology.2003
;37:788
-794.
